Xenon Pharmaceuticals Inc.

NASDAQ
XENE
Stock
Yield per half year: -18.41%
Dividend yield: 0%
Sector: Healthcare

Reporting Xenon Pharmaceuticals Inc.

Capitalization

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Average for 5 years CAGR 5
Capitalization, bln $
0.1817 0.1339 0.078 0.1963 0.3159 0.4638 0.8532 2.47 2.47 2.34 1.31 50.88
Revenue, bln $
0.0284 0.0156 0.0018 0.000311 0.0068 0.0322 0.0184 0.0094 0.0132 0.0094 0.0160 14.19
Net profit, bln $
-0.023 -0.0307 -0.0345 -0.0416 -0.0288 -0.0789 -0.1254 -0.1824 -0.2343 -0.2343 -0.1300 52.08
EV, bln $
0.0643 0.0807 0.3354 0.4896 1.2 2.26 2.85 2.87 2.87 1.93 42.43
EBIT, bln $
-0.0253 -0.0334 -0.0331 -0.0428 -0.0286 -0.079 -0.1291 -0.2141 -0.2384 -0.2384 -0.1378 52.82
EBITDA, bln $
-0.0221 -0.0301 -0.0339 -0.0412 -0.0307 -0.0781 -0.1275 -0.2105 -0.2359 -0.2359 -0.1365 50.36
OIBDA $
-0.0331 -0.0782 -0.1313 -0.2422 -0.2808 -0.2808 -0.1531 53.36
Book value, bln $
0.0639 0.0359 -0.2079 -0.2497 -0.2785 -0.3574 0.7215 0.9279 0.7549 0.7549 0.3537 -222.07
FCF, bln $
-0.0198 -0.029 -0.0352 -0.0059 -0.0508 -0.0716 -0.1013 -0.1509 -0.1845 -0.1845 -0.1118 29.43
Operating Cash Flow, bln $
-0.0196 -0.0287 -0.0347 -0.0046 -0.0481 -0.0695 -0.0984 -0.1453 -0.1814 -0.1814 -0.1085 30.41
Operating profit, bln $
-0.0248 -0.0326 -0.038 -0.0428 -0.0313 -0.079 -0.1291 -0.2141 -0.2793 -0.2793 -0.1466 54.92
Operating expenses, bln $
0.0266 0.0329 0.032 0.0496 0.0635 0.0974 0.1386 0.0465 0.2793 0.2793 0.1251 34.48
CAPEX, bln $
0.000279 0.000315 0.000507 0.0012 0.0026 0.0021 0.0029 0.0056 0.0031 0.0031 0.0033 3.58


Balance sheet

IFRS
Reporting Annual Quarterly
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Average for 5 years CAGR 5
Cash, bln $
0.0171 0.0205 0.1193 0.1414 0.177 0.1757 0.0572 0.1486 0.1427 0.1427 0.1402 -4.22
Short-Term Investments $
0.0471 0.0232 0.0516 0.1166 0.132 0.3761 0.5348 0.4894 0.4842 0.4842 0.4033 29.69
Long-Term Investments $
0.1287 0.2928 0.2107 50.83
Accounts Receivable $
0.0002 0.000438 0.000256 0.000813 0.0018 0.0028 0.000986 0.000874 0.0015 0.0015 0.0016 -3.58
Total Current Assets $
0.0657 0.0448 0.1214 0.1449 0.1818 0.559 0.6003 0.645 0.6353 0.6353 0.5243 28.43
Net assets, bln $
0.002 0.0014 0.0011 0.1033 0.092 0.1714 0.55 0.0065 0.6869 0.0065 0.3014 49.49
Assets, bln $
0.0675 0.0461 0.1224 0.1477 0.1892 0.572 0.7541 0.9648 0.7981 0.7981 0.6556 33.36
Short-Term Debt $
0.0007 0.015 0.0048 0.000265 0.000605 0.000488 0.0013 0.0014 0.0014 0.0008 39.50
Long-Term Debt $
0.0017 0.0061 0.015 0.0109 0.0084 59.13
Liabilities, bln $
0.0036 0.0102 0.0191 0.0557 0.0178 0.022 0.0326 0.0369 0.0432 0.0432 0.0305 19.40
Net debt, bln $
-0.0171 -0.0137 -0.0527 -0.0083 -0.0417 -0.1674 -0.0468 -0.1377 -0.1337 -0.1337 -0.1055 26.24
Debt, bln $
0.0068 0.015 0.0047 0.0033 0.0083 0.0104 0.0109 0.009 0.009 0.0084 22.22
Interest Income $
0.0064 0.000504 0.000477 0.0012 0.0024 0.0023 0.000466 0.0087 0.0234 0.0075 57.69
Interest Expense, bln $
0.0001 0.0001 0.0001 0.0014 0.0014 0.000484 0.001 0.0055 0.0167 0.0055 0.0050 64.18
Net interest income, bln $
0.000504 0.000477 0.0012 0.0024 0.0023 0.000466 0.0087 0.0234 0.0234 0.0075 57.69
Amortization, bln $
0.0000 0.0001 0.000586 0.0028 0.000644 0.000906 0.0016 0.0035 0.0026 0.0026 0.0018 32.20
Cost of production, bln $
0.0011 0.0256 0.006 0.0388 0.0505 0.0755 0.1058 0.1675 0.0026 0.0026 0.0804 -44.75
Inventory $
0 0 -0.000315 0 0 0.0018 0.0028 0.000986 0 0 0.0013 -233.01


Share

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Average for 5 years CAGR 5
EPS -1.48 -1.71 -1.78 -1.6 -0.8348 -1.81 -2.07 -2.73 -3.01 -3.01 -2.0910 29.24
Share price 4.38 7.62 9.52 12.6 20.71 39.53 46.06 39.2 32.76 32.76 35.65 9.61
Number of shares, mln 17.97 17.8 19.43 25 34 43 60.54 66.89 77.89 77.89 56.46 18.03
FCF/share -1.1 -1.63 -1.81 -0.2264 -1.47 -1.64 -1.67 -2.26 -2.37 -2.37 -1.8820 10.02


Efficiency

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
ROE, % -35.99 -85.45 -33.4 -45.22 -16.83 -14.34 -19.72 -22.12 -27.85 -27.85 17.60 -20.1720 10.60
ROA, % -34.08 -66.57 -28.18 -28.16 -15.24 -13.79 -18.91 -21.22 -26.58 -26.58 5.71 -19.1480 11.77
ROIC, % 15.26 -15.34 -38.84 -77.49 -32.11 -41.6 -18.11 -14.36 17.65 -36.7340 -28.62
ROS, % -1376.43 -10474.28 -588.43 -88.94 -427.88 -1328.95 -1334.04 -1940.35 -2492.87 -2492.87 13.36 -1504.8180 42.26
ROCE, % -92.87 -27.98 -41.05 -16.4 -14.16 -17.66 -22.83 -31.27 -31.58 -31.58 29.73 -23.5000 17.40
EBIT margin -588.8 -97.31 -428.45 -1368.91 -2536.37 -2536.37 18.53 -1003.9680 33.92
EBITDA margin -94.46 -1227.57 -9663.99 -603.15 -88.45 -422.96 -1351.7 -840.1 -2509.14 -2509.14 26.10 -1042.4700 95.24
Net margin 45.89 -101.12 -1275.49 -9872.67 -609.09 -89.65 -427.85 -1328.95 -21784.49 -1328.95 13.36 -4848.0060 104.50
Operational efficiency, % -1376.43 -10474.28 -627.02 -97.31 -428.45 -1368.91 -1373.4 -2277.17 -2971.26 -2971.26 16.64 -1683.8380 47.30
FCF yield, % -0.6053 -10.26 -14.82 -37.23 -17.95 -1.86 -10.94 -8.39 -4.65 -5.78 -6.3240 25.45


Coefficients

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
P/E
62.5 -21.03 -13.79 -3.79 -7.53 -12.98 -21.97 -16.31 -17.37 -14.33 69.12 -16.5920 2.00
P/BV
4.96 3.24 2.52 5.87 3.7 2.34 3.2 3.22 3.98 3.98 8.87 3.29 1.47
P/S
28.68 21.26 175.92 374.18 79.08 19.7 69.8 244.38 172.01 244.38 8.05 116.99 16.81
P/FCF
-4.01 -7.38 -91.97 -12.48 -17.99 -21.5 -23.1 -15.5 -12.69 -12.69 8.97 -18.1560 -6.74
E/P
-0.3936 -0.1757 -0.1317 -0.0622 -0.0925 -0.0576 -0.0698 -0.0779 -0.1001 -0.1001 0.03 -0.0796 1.59
EV/EBIT
-8.34 -15.64 -15.13 -17.49 -13.3 -12.03 -12.03 -12.03 88.11 -13.9960 -4.48
EV/EBITDA
-13.56 -3.42 -6.11 -12.89 -20.7 -14.26 -17.71 -13.53 -12.16 -12.16 53.63 -15.6720 -10.09
EV/S
206.84 44.93 15.22 64.84 239.41 240.43 302.93 305.06 305.06 8.36 230.53 36.30
EV/FCF
-2.22 -4.5 -52.25 -9.64 -16.71 -22.29 -18.86 -15.55 -15.55 -15.55 21.77 -17.7920 -1.43
Debt/EBITDA
-0.2042 -0.8292 -0.3923 -0.1081 -0.1057 -0.0818 -0.0518 -0.0382 -0.0382 -0.0382 2.61 -0.0631 -18.42
Netdebt/Ebitda
0.46 1.56 0.22 1.57 2.25 0.3671 0.6543 0.5669 0.5669 0.5669 0.49 0.8810 -24.10
Debt/Ratio
0.22 0.16 0.38 0.09 0.04 0.0138 0.0113 0.0113 0.0113 0.0113 0.24 0.0175 -22.34
Debt/Equity
0.28 0.19 0.61 0.1 0.04 0.0145 0.0117 0.0119 0.0573 0.0573 2.82 0.0271 7.45
Debt/Net Income
-0.2216 -0.8705 -0.3776 -0.115 -0.1047 -0.0832 -0.0598 -0.0385 -0.0385 -0.0385 10.75 -0.0649 -18.13
PEG
0 0 -67.37
Beta
1.32 1.91 -0.2402 -0.6429 -0.6429 -0.03 0.5867 -183.54
Altman Index
0.33 5.9 3.42 19.99 34.98 0 3.26 2.49 2.96 2.96 12.59 12.74 -31.75


Dividends

IFRS
Reporting Annual
2022 2023 LTM Industry average Average for 5 years CAGR 5
Dividend
0
Dividend yield, %
0 1.71
Dividends / profit, %
0 0 0 155.02


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 CAGR 5
Total Debt
0.0041 0.0434 0.0148 53.40
CAPEX/Revenue, %
8.2 11.12 30.68 55.24
Staff, people
149 203 251 18.99